<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078504</url>
  </required_header>
  <id_info>
    <org_study_id>26817</org_study_id>
    <nct_id>NCT03078504</nct_id>
  </id_info>
  <brief_title>Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy</brief_title>
  <official_title>Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Louis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Louis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood
      flow rates in critically ill patients receiving continuous renal replacement therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood pressure change</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>End-stage Renal Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous renal replacement therapy using System One (TM) setup (Nxstage)</intervention_name>
    <description>Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates</description>
    <other_name>NxStage</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-89

          -  Acute renal failure or end-stage renal disease necessitating CRRT

          -  Admitted to the MICU service

          -  If on vasopressor/inotropic agent, norepinephrine as only intravenous pressor

          -  If on vasopressor/inotropic agent, at stable pressor dose for at least four hours

          -  If on IV fluids, stable dose of crystalloids &lt;= 100cc/hour and is not receiving
             colloids for 4 hours or more prior to initiation of CRRT

          -  Mean arterial pressure (MAP) &gt;= 65

          -  Arterial catheter present for continuous blood pressure monitoring

          -  CRRT duration of 48 hours or less using NxStage System One dialysis system

          -  successfully tolerated CRRT for at least 4 hours without clotting or hemodynamic
             instability

          -  no other procedures, blood products transfusion, or additional medication
             administration are anticipated during the study period

        Exclusion Criteria:

          -  listed for organ transplant

          -  atrial fibrillation, other irregular heart rhythm, unstable arrhythmia

          -  need for more than one intravenous vasopressor agent

          -  intravenous vasopressor/inotropic agent other than norepinephrine (ie dobutamine,
             dopamine, vasopressin, epinephrine)

          -  therapeutic anticoagulation being administered

          -  known acute myocardial infarction as defined by elevated troponin along with a
             documented clinical diagnosis during current hospitalization

          -  known acute stroke, intracerebral hemorrhage, intracranial mass effect, or elevated
             intracranial pressure within the last 30 days.

          -  dialysis catheter malfunction and unable to maintain target blood flow rate

          -  fluid removal (ultrafiltration) rate &gt; 100mL/hour
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>sadashiv santosh, md</last_name>
    <phone>314-577-8856</phone>
    <email>santoshs@slu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sadashiv santosh, md</last_name>
      <phone>314-577-8856</phone>
      <email>santoshs@slu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Louis University</investigator_affiliation>
    <investigator_full_name>Sadashiv Santosh, MD</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

